Comparative Pharmacology
Head-to-head clinical analysis: MAFENIDE ACETATE versus SILVADENE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAFENIDE ACETATE versus SILVADENE.
MAFENIDE ACETATE vs SILVADENE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Mafenide acetate is a sulfonamide antibiotic that inhibits bacterial folic acid synthesis by competitively antagonizing para-aminobenzoic acid (PABA), thereby preventing bacterial growth. It has broad-spectrum activity against gram-negative and gram-positive organisms, including Pseudomonas aeruginosa.
Silver sulfadiazine exerts bactericidal activity by releasing silver ions that bind to microbial DNA and proteins, inhibiting cell wall synthesis and cell division. The sulfadiazine component provides additional bacteriostatic action by competing with para-aminobenzoic acid (PABA) to inhibit dihydropteroate synthase in folic acid synthesis.
Apply topically as a thin layer to affected areas once or twice daily. The dosage form is an 11.1% cream or solution. The cream is applied using a sterile gloved hand; the solution is applied with a sterile spray or brush.
Apply a thin layer (approximately 1/16 inch) of 1% cream to the affected area once or twice daily. Use a sterile gloved hand. Reapply as needed to maintain coverage.
None Documented
None Documented
Approximately 45 minutes (range 30-60 minutes) for the parent compound; the metabolite p-CBS has a longer half-life of about 4 hours.
The terminal elimination half-life of sulfadiazine is approximately 10-12 hours in patients with normal renal function. Silver has a very long biological half-life (weeks to months) due to tissue deposition.
Renal: approximately 80% excreted unchanged in urine; the remainder is metabolized to p-carboxybenzene sulfonamide (p-CBS) which is also renally excreted.
Silver sulfadiazine applied topically results in minimal systemic absorption. The sulfadiazine component is primarily excreted renally (approximately 70% as unchanged drug and metabolites), with biliary/fecal excretion accounting for a small fraction (<10%). Silver is largely retained in tissues, not excreted.
Category C
Category C
Topical Antibiotic
Topical Antibiotic